New Search

If you are not happy with the results below please do another search

Search
Generic filters

50 search results for:

1

Relief, NeuroRx say emergency treatment with RLF-100 helps critically ill Covid patients

Critically ill Covid-19 patients recovered rapidly from respiratory failure after three days of treatment with RLF-100, a therapy granted fast-track designation in the United States, two drug companies said on Sunday.

3

FDA Approves Monjuvi for Treatment of DLBCL

FDA Approves Monjuvi® (tafasitamab-cxix) in Combination With Lenalidomide for the Treatment of Adult Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL) – First FDA approval of a second-line treatment for adult patients with relapsed or refractory DLBCL, helping fill a high unmet medical need – FDA granted Monjuvi Fast Track, Breakthrough Therapy and […]

5

GSK and Sanofi Strike $2.1 Billion Deal with U.S. Government for 100 Million Doses of Covid-19 Vaccine

GlaxoSmithKline and Sanofi struck a $2.1 billion deal with the U.S. government’s Operation Warp Speed program to supply an initial 100 million doses of a Covid-19 vaccine candidate under development by the two companies.

9

Research Roundup: Can Flu and Pneumonia Vaccines Prevent Alzheimer’s and More

A review of recently published scientific studies includes a look at the potential of using flu and pneumonia vaccines to decrease the risk of developing Alzheimer’s disease.